| 缩写名/全名 |
ARCH PHARM
ARCHIV DER PHARMAZIE |
||||||||||||||||||||
| ISSN号 | 0365-6233 | ||||||||||||||||||||
| 研究方向 | 医学-化学综合 | ||||||||||||||||||||
| 影响因子 | 2015:2.043, 2016:1.994, 2017:2.288, 2018:2.145, 2019:2.59, | ||||||||||||||||||||
| 出版国家 | GERMANY | ||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||
| 年文章数 | 100 | ||||||||||||||||||||
| 出版年份 | 1972 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||
| 投稿链接 | http://mc.manuscriptcentral.com/archpharm | ||||||||||||||||||||
| 投稿官网 | http://onlinelibrary.wiley.com/doi/10.1002/ardp.v344.10/issuetoc | ||||||||||||||||||||
| h-index | 54 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0365-6233%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamides. Author: Wang Y1,2, Wang X3, Chen X1, Liu X1,2. Journal: Arch Pharm (Weinheim). 2019 Jan;352(1):e1800257. doi: 10.1002/ardp.201800257. Epub 2018 Nov 30. PubMed DOI |
| 2. | Semi-synthesis, antibacterial activity, and molecular docking study of novel pleuromutilin derivatives bearing cinnamic acids moieties. Author: Deng Y1, Tang D1, Wang QR2, Huang S1, Fu LZ1, Li CH1. Journal: Arch Pharm (Weinheim). 2019 Jan;352(1):e1800266. doi: 10.1002/ardp.201800266. Epub 2018 Dec 7. PubMed DOI |
| 3. | Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate. Author: Xie BC1, Song SY1, Xie XY1, Sun YT1, Zhang XY2, Xu DH1, Huang YS1. Journal: Arch Pharm (Weinheim). 2019 Mar;352(3):e1800295. doi: 10.1002/ardp.201800295. Epub 2019 Jan 2. PubMed DOI |
| 4. | Liposomes actively recognizing the glucose transporter GLUT1 and integrin αv β3 for dual-targeting of glioma. Author: Fu Q1, Zhao Y1, Yang Z1, Yue Q1, Xiao W1, Chen Y1, Yang Y1, Guo L1, Wu Y1. Journal: Arch Pharm (Weinheim). 2019 Feb;352(2):e1800219. doi: 10.1002/ardp.201800219. Epub 2019 Jan 4. PubMed DOI |
| 5. | Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review. Author: Jinhua W1. Journal: Arch Pharm (Weinheim). 2019 Mar;352(3):e1800222. doi: 10.1002/ardp.201800222. Epub 2019 Jan 21. PubMed DOI |
| 6. | Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions. Author: Zhang NN1, Tang YX2,3, Qian L1, Gao YM2,4, Liu ZY2, Zou ZL1, Zhang TY2,4, Yan M1. Journal: Arch Pharm (Weinheim). 2019 Apr;352(4):e1800277. doi: 10.1002/ardp.201800277. Epub 2019 Jan 30. PubMed DOI |
| 7. | Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics. Author: Xu M1,2, Guo S1,2, Yang F1, Wang Y1, Wu C3, Jiang X1, Zhao Q1, Chen W3, Tian G3, Zhu F3, Xie Y1, Hu T3, Wang Z1, He Y1, Shen J1. Journal: Arch Pharm (Weinheim). 2019 Apr;352(4):e1800306. doi: 10.1002/ardp.201800306. Epub 2019 Jan 31. PubMed DOI |
| 8. | Discovery and biological evaluation of novel G protein-coupled receptor 119 agonists for type 2 diabetes. Author: Zhou Y1, Wang Y2, Zhang L1, Tang C1, Feng B1. Journal: Arch Pharm (Weinheim). 2019 Apr;352(4):e1800267. doi: 10.1002/ardp.201800267. Epub 2019 Feb 10. PubMed DOI |
| 9. | Design, synthesis, and biological evaluation of novel 4-phenoxypyridine derivatives as potential antitumor agents. Author: Liu J1, Liu Y1, Hao X1, Wang Y1, Ji J1, Liu Y2, Ding S1, Chen Y1. Journal: Arch Pharm (Weinheim). 2019 May;352(5):e1800338. doi: 10.1002/ardp.201800338. Epub 2019 Mar 19. PubMed DOI |
| 10. | Quinolone derivatives and their antifungal activities: An overview. Author: Zhang B1. Journal: Arch Pharm (Weinheim). 2019 May;352(5):e1800382. doi: 10.1002/ardp.201800382. Epub 2019 Apr 25. PubMed DOI |
|
|
